Please login to the form below
The Prime Medical Group
This page shows the latest The Prime Medical Group news and features for those working in and with pharma, biotech and healthcare.
The Prime Medical Group rebrands as Prime Global
Moves to highlight healthcare communications group’s international status. Medical communications specialist The Prime Medical Group has undergone a rebrand, changing its name to Prime Global. ... Graeme Peterson, group chairman and chief executive
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest appointments
-
The Prime Medical Group strengthens leadership team
Karen Turner and Gauri Saal join the comms agency. Global communications agency The Prime Medical Group has appointed Karen Turner as vice president of client services and Gauri Saal as principal ... She joins The Prime Medical Group from Watermeadow
-
Creative directors join The Prime Medical Group’s UK offices
Adam Moriarty and Craig Armstrong join London and Cheshire teams. Medical education and communications firm The Prime Medical Group has appointed two new creative directors to its UK offices. ... Meanwhile, Craig Armstrong (pictured above) joins The
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
Prime Global
Prime Global- The medical communications people. Prime Global is a group of six full-service medical communications agencies and specialist consultancies. ... Prime Global.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Commercial Director, Medical Education, UK six figure package
-
Six figure salary
- Senior Account Manager, Patient/ Medical Communications agency, ...
-
Highly competitive salary
- Lilly’s donanemab shows promise in early symptomatic Alzheimer's comparator study
- AstraZeneca to acquire Neogene Therapeutics in $320m deal
- Biogen and Eisai’s Alzheimer’s drug shown to slow memory decline in confirmatory study
- Gilead’s Biktarvy received EC approval for the treatment of HIV in paediatric populations
- MHRA approves LEO Pharma’s Adtralza for adolescent patients with atopic dermatitis
- Bayer’s Nubeqa receives MHRA approval to treat metastatic prostate cancer
- ORIGINS cements its specialist position with a truly patient focused offering
- Pfizer/BioNTech submit FDA application for BA.4/BA.5 COVID-19 vaccine in children under five
- Antibiotics may be given to UK schools affected by strep A
- LEO Pharma’s delgocitinib cream shows promise in phase 3 chronic hand eczema study
- Valneva’s chikungunya vaccine candidate shows promise in antibody persistence trial
- Kinarus’ KIN001 shows strong antiviral activity against BA.2 and BA.5 Omicron subvariants
- Locus Biosciences announces first patient treated in urinary tract infection trial
- AstraZeneca and C4X Discovery sign exclusive $403m licensing deal
- UK Government announces £113m to tackle ‘biggest’ public health challenges
- Environment: where does the pharmaceutical industry stand?
- Putting the ovation into innovation: trends from ESMO
- Bayer’s Nubeqa receives MHRA approval to treat metastatic prostate cancer
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings
- ...
- Influenza – the risk to vulnerable populations
- Why we can't get complacent about flu vaccination...
- Alzheimer’s Research UK highlights socio-economic inequalities in dementia risk
- The charity aims to improve the number of women participating in dementia research and grow awareness of dementia risk factors...
